These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8258 related articles for article (PubMed ID: 11103670)
41. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred. Petronzelli F; Sollima D; Coppola G; Martini-Neri ME; Neri G; Genuardi M Genes Chromosomes Cancer; 2001 Aug; 31(4):398-401. PubMed ID: 11433531 [TBL] [Abstract][Full Text] [Related]
42. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families. Goldstein AM; Martinez M; Tucker MA; Demenais F Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905 [TBL] [Abstract][Full Text] [Related]
43. CDKN2A mutations in melanoma families from Uruguay. Larre Borges A; Cuéllar F; Puig-Butillé JA; Scarone M; Delgado L; Badenas C; Milà M; Malvehy J; Barquet V; Núñez J; Laporte M; Fernández G; Levrero P; Martínez-Asuaga M; Puig S Br J Dermatol; 2009 Sep; 161(3):536-41. PubMed ID: 19523171 [TBL] [Abstract][Full Text] [Related]
44. A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families. Yakobson E; Eisenberg S; Isacson R; Halle D; Levy-Lahad E; Catane R; Safro M; Sobolev V; Huot T; Peters G; Ruiz A; Malvehy J; Puig S; Chompret A; Avril MF; Shafir R; Peretz H; Bressac-de Paillerets B Eur J Hum Genet; 2003 Apr; 11(4):288-96. PubMed ID: 12700603 [TBL] [Abstract][Full Text] [Related]
45. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Yarbrough WG Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329 [TBL] [Abstract][Full Text] [Related]
46. Head and neck squamous cell carcinoma in FAMMM syndrome. Vinarsky V; Fine RL; Assaad A; Qian Y; Chabot JA; Su GH; Frucht H Head Neck; 2009 Nov; 31(11):1524-7. PubMed ID: 19360740 [TBL] [Abstract][Full Text] [Related]
47. Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations. Vignoli M; Scaini MC; Ghiorzo P; Sestini R; Bruno W; Menin C; Gensini F; Piazzini M; Testori A; Manoukian S; Orlando C; D'Andrea E; Bianchi-Scarrà G; Genuardi M Melanoma Res; 2008 Dec; 18(6):431-7. PubMed ID: 19011513 [TBL] [Abstract][Full Text] [Related]
48. Familial head and neck cancer: molecular analysis of a new clinical entity. Yu KK; Zanation AM; Moss JR; Yarbrough WG Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668 [TBL] [Abstract][Full Text] [Related]
49. Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Helsing P; Nymoen DA; Ariansen S; Steine SJ; Maehle L; Aamdal S; Langmark F; Loeb M; Akslen LA; Molven A; Andresen PA Genes Chromosomes Cancer; 2008 Feb; 47(2):175-84. PubMed ID: 18023021 [TBL] [Abstract][Full Text] [Related]
50. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family. Knappskog S; Geisler J; Arnesen T; Lillehaug JR; Lønning PE Genes Chromosomes Cancer; 2006 Dec; 45(12):1155-63. PubMed ID: 17001621 [TBL] [Abstract][Full Text] [Related]
51. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184 [TBL] [Abstract][Full Text] [Related]
52. Melanoma ex naevo: a study of the associated naevus. Bogdan I; Smolle J; Kerl H; Burg G; Böni R Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309 [TBL] [Abstract][Full Text] [Related]
53. New developments in melanoma genetics. Hayward N Curr Oncol Rep; 2000 Jul; 2(4):300-6. PubMed ID: 11122857 [TBL] [Abstract][Full Text] [Related]
54. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388 [TBL] [Abstract][Full Text] [Related]
55. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
56. Family members' perceptions of genetic testing for malignant melanoma--a prospective interview study. Bergenmar M; Hansson J; Brandberg Y Eur J Oncol Nurs; 2009 Apr; 13(2):74-80. PubMed ID: 19179113 [TBL] [Abstract][Full Text] [Related]
57. Dysplastic nevi and other risk markers for melanoma. Seykora J; Elder D Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587 [TBL] [Abstract][Full Text] [Related]
58. Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases. Levanat S; Situm M; Crnić I; Marasović D; Puizina-Ivić N; Pokupcić N; Musani V; Komar A; Kubat M; Furac I; Karija-Vlahović M; Krizanac S Croat Med J; 2003 Aug; 44(4):418-24. PubMed ID: 12950144 [TBL] [Abstract][Full Text] [Related]